0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

CLINICAL NOTES   |    
CLINICAL AND STATISTICAL EVALUATION OF RESULTS WITH PLEGICIL AY-57062 IN CHRONIC MENTAL PATIENTS
E. J. TOLAN; J. OLARIU; J. M. REES; H. A. PEPPEL
Am J Psychiatry 1959;116:69-71.
View Author and Article Information

Columbus State Hosp., Columbus Ohio.

Ionis State Hosp., Ionia Mich.

Staff Psychiatrist at Hawthornden State Hospital, Macedonia, Ohio.

Superintendent, Hawthornden State Hosp., Macedonia, Ohio.

text A A A
PDF of the full text article.
Abstract

Acepromazine was tried in 48 chronic mental patients, 12 male and 36 female. Their ages ranged from 22 to 61 years, and the time elapsed from their first admission in a mental hospital ranged from 1 to 29 years.The majority of the patients were suffering from various types of schizophrenic reactions, and no significant number of other diagnostic categories was included.Acepromazine was administered orally for an average of 16 weeks. The highest daily dosage reached 120 mg., with an average of 99.58 mg. The drug did improve symptoms and behavior in a significant manner.Thirty-seven out of the 48 patients showed some improvement; 7 showed no change; 1 patient worsened. The other 3 patients worsened and developed toxic reactions; the medication was discontinued and the patients were removed from the study.There was a slight indication that younger patients and those admitted recently were helped more than older patients or those whose first admission was many years ago. There was no significant difference in the effect of acepromazine on various diagnostic categories. There was no relation between the total length of the medication and the degree of improvement. There was a slight but not significant indication that a slower increment in dosage results in greater improvement than a faster increment. Two main areas, Psychotic Symptoms and Behavioral Traits, improved more than Intellectual Resources, Character Traits and Interpersonal Relationships, and Socialization and Rehabilitation, but the improvement in Behavioral Traits is not significantly correlated with the improvement in the Psychotic Symptoms.With the exception of 3 patients for whom the drug had to be discontinued because of toxic reaction characterized by extreme agitation, confusion and weakness, very few side effects have occurred and none was serious. No jaundice or allergic reactions were noted, and a very low incidence of Parkinsonism was encountered. No relation was found between the number or the type of the side effects, including Parkinsonism, and the degree of improvement.Finally, it was noted that in this series of patients, acepromazine proved effective where other drugs or EST were not and that of the 7 patients who showed no improvement on acepromazine, none had improved on previous chemotherapy or EST.

Abstract Teaser
Figures in this Article

Your Session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
 
Username
Password
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

+

References

+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content
Articles
Books
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 67.  >
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 34.  >
Textbook of Psychotherapeutic Treatments > Chapter 20.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 22.  >
The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 38.  >
Topic Collections
Psychiatric News
PubMed Articles